Ask AI

Expert Think Tank: From Evidence to Practice—Navigating Controversies in Bridging Therapy in Myeloma CAR-T Treatment

Gain expert insights into the role and benefits of bridging therapy prior to CAR T-cell treatment in patients with multiple myeloma to optimize outcomes through a ClinicalThought commentary, certified text modules, and accompanying downloadable slides.

Share

Program Content

Activities

CAR T Bridging in MM
Optimizing Bridging Therapy: Selection and Timing to Support CAR T-Cell Success in MM
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2025

Expires: April 29, 2026

Barriers to CAR T Cell Therapy
From Evidence to Practice—Barriers to Access and Manufacturing Delays in CAR T-Cell Therapy
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2025

Expires: June 08, 2026

Selecting Patients for Bridging Therapy in RR MM
Identifying Patients Likely to Benefit From Bridging Therapy Before CAR T-Cell Infusion  in R/R MM 
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 29, 2025

Expires: June 28, 2026

Activities

CAR T Cell Therapy in MM
Barriers to Access and Manufacturing Delays in CAR T-Cell Therapy 
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2025

Selecting Bridging Therapy
Optimizing Bridging Therapy: Selection and Timing to Support CAR T-Cell Success in MM
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2025

Bridging Therapy Patient Selection R/R MM
Selecting Patients to Receive Bridging Therapy Before CAR-T in R/R MM
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 29, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson